A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy

BACKGROUND: Because of rapid disease progression and lack of optimal treatment strategies beyond the second‐line, the prognosis of patients with extensive‐stage (ES) small cell lung cancer (SCLC) still remains depressing. Alternative treatment strategies are required to improve their prognosis. In t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Liu, Yutao, Hu, Xingsheng, Jiang, Jun, Yang, Lin, Zhou, Shengyu, Liu, Peng, Li, Junling, Wang, Yan, Hao, Xuezhi, Shi, Yuankai
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2020
Konular:
Lung Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216448/
https://ncbi.nlm.nih.gov/pubmed/32250517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0391
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller